Cisplatin bioavailability
WebSep 1, 2024 · The present study explored the efficacy of cisplatin coated albumin nanoparticle as a sustained delivery system.To attain this goal, cisplatin was loaded onto albumin nanoparticles (NPs),... WebHyponatremia of grade 3 or above developed in 30.7% of the generic CDDP group compared to 15.1% of the brand-name CDDP group ( P =0.011). Multivariate analysis showed that the use of generic CDDP increased the incidence of hyponatremia (odds ratio =5.661, 95% confidence interval =1.403–22.839; P =0.015). Conclusion: Oncologists …
Cisplatin bioavailability
Did you know?
WebIntroduction: Cisplatin has been indicated for several malignancies all over the world for many years. Increasing patient tolerance for high dose of chemotherapeutics and reducing side effects... WebIn attempts to overcome the drawbacks of cisplatin - severe toxicity, drug resistance and poor oral bioavailability - the development of platinum-based drugs has progressed from carboplatin and oxaliplatin to the newest generation of drugs, such as satraplatin, picoplatin and the multinuclear platinum complex BBR3464 (triplatin).
WebAug 16, 2024 · Like gemcitabine and cisplatin as chemotherapeutic medications, it inhibits the development of malignant cells with IC 50 ranging from 5 to 30 μM [148,149,150]. A clinical trial involving 15 people with colorectal cancer found that the cancer was unresponsive to curcumin at 3.6 g/day over four months [ 151 ]. WebFeb 16, 2024 · 50 to 70 mg/m2 by slow IV infusion once every 3 to 4 weeks; for heavily pretreated patients, an initial dose of 50 mg/m2 by slow IV infusion once every 4 weeks …
Cisplatin is a platinum based chemotherapy agent used to treat various sarcomas, carcinomas, lymphomas, and germ cell tumors. Brand Names. Platinol. Generic Name. Cisplatin. DrugBank Accession Number. DB00515. Background. Cisplatin, cisplatinum or cis-diamminedichloroplatinum (II) (CDDP) is a … See more WebNov 21, 2024 · The route of administration will have a direct impact on poor drug bioavailability, especially if administrated via the systemic route due to incomplete absorption or degradation. In conventional drug delivery …
WebFeb 1, 2005 · Cisplatin is the first choice treatment in mediastinal germ cell tumors. However, concerns regarding increased toxicity of cisplatin hamper its administration in … curls brows n braidsWeb3.4.4 Bioavailability 3.4.5 Specific properties and composition 4. USES 4.1 Indications 4.2 Therapeutic Doses 4.3 Contraindications 5. ROUTES OF ENTRY 5.1 Oral 5.2 Inhalation … curls by alexionWeb(cisplatin for injection, USP) is a white to light yellow lyophilized powder. Each vial of PLATINOL contains 50 mg cisplatin, 450 mg Sodium Chloride, USP, and 500 mg Mannitol, USP. The active... curls businessWebCisplatin (2/9), Doxorubicin (3/9) and Paclitaxel (4/9) were the chemotherapeutic agents used in these nine studies. The posology, the administration mode and the timing of intervention were very heterogeneous among the studies. curls brush photoshopWebJul 22, 2024 · Cisplatin represents a promising chemotherapeutic compound in neoadjuvant approaches and in the metastatic setting, but its use is limited by scarce bioavailability, severe systemic side effects and drug resistance. Novel site-directed aptamer-based nanotherapeutics have the potential to overcome obstacles of chemotherapy. curls brandWebJan 1, 1985 · Cisplatin is generally synthesised by the ammonolysis of potassium tetrachloroplatinate (K 2 PtC1 4 ). The absorption spectrum of cisplatin (1.0 mg/ml) has been obtained in 0.1 N HCl using a Cary 15 and 2.0 cm cells.The spectrum shows three maxima at 203 nm, 301 nm, and 362 nm, a “shoulder” at 285 nm, and minima at 246 nm … curls by bibioWebJul 7, 2014 · Cisplatin exerts its toxicity by DNA binding and downstream apoptotic signaling, and resistance is conferred by reducing apoptotic signaling, up-regulating DNA … curls by jami